Capricor Therapeutics (CAPR) FCF Margin Growth (1y) (2012 - 2024)
Capricor Therapeutics (CAPR) FCF Margin Growth (1y) (2012 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Capricor Therapeutics |
1.53 Bn |
1.26 Bn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
-3,679.00 |
| Sep 30, 2024 |
-36,865.00 |
| Jun 30, 2024 |
-6,707.00 |
| Mar 31, 2024 |
-14,809.00 |
| Dec 31, 2023 |
69,081.00 |
| Sep 30, 2023 |
24,574.00 |
| Jun 30, 2021 |
188,979.00 |
| Mar 31, 2021 |
-759,145.00 |
| Dec 31, 2020 |
-633,881.00 |
| Sep 30, 2020 |
-1.74 Mn |
| Jun 30, 2020 |
-382,673.00 |
| Mar 31, 2020 |
4,147.00 |
| Dec 31, 2019 |
-22,421.00 |
| Sep 30, 2019 |
26,408.00 |
| Jun 30, 2019 |
48,073.00 |
| Mar 31, 2019 |
20,343.00 |
| Dec 31, 2018 |
-1,890.00 |
| Sep 30, 2018 |
-40,305.00 |
| Jun 30, 2018 |
27,217.00 |
| Mar 31, 2018 |
-36,968.00 |
